Chemours Ownership
| CC Stock | USD 14.74 0.14 0.96% |
Shares in Circulation | First Issued 2014-09-30 | Previous Quarter 150 M | Current Value 150 M | Avarage Shares Outstanding 170.3 M | Quarterly Volatility 13.8 M |
Chemours |
Chemours Stock Ownership Analysis
About 86.0% of the company shares are held by institutions such as insurance companies. The book value of Chemours was currently reported as 4.04. The company has Price/Earnings To Growth (PEG) ratio of 1.67. Chemours last dividend was issued on the 28th of February 2025. The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. The Chemours Company was founded in 2014 and is headquartered in Wilmington, Delaware. Chemours operates under Specialty Chemicals classification in the United States and is traded on New York Stock Exchange. It employs 6400 people. For more info on Chemours Co please contact Mark Vergnano at 302 773 1000 or go to https://www.chemours.com.Besides selling stocks to institutional investors, Chemours also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Chemours' stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Chemours' strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Chemours Quarterly Liabilities And Stockholders Equity |
|
Chemours Insider Trades History
Less than 1% of Chemours Co are currently held by insiders. Unlike Chemours' institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Chemours' private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Chemours' insider trades
Chemours Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Chemours is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Chemours Co backward and forwards among themselves. Chemours' institutional investor refers to the entity that pools money to purchase Chemours' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Ubs Group Ag | 2024-12-31 | 2.1 M | Norges Bank | 2024-12-31 | 1.8 M | Dimensional Fund Advisors, Inc. | 2024-12-31 | 1.8 M | American Century Companies Inc | 2024-12-31 | 1.6 M | Massachusetts Financial Services Company | 2024-12-31 | 1.6 M | Morgan Stanley - Brokerage Accounts | 2024-12-31 | 1.6 M | Mackenzie Investments | 2024-12-31 | 1.6 M | Vision One Management Partners Lp | 2024-12-31 | 1.6 M | Scopia Management Inc | 2024-12-31 | 1.4 M | Blackrock Inc | 2024-12-31 | 16.8 M | Vanguard Group Inc | 2024-12-31 | 15.2 M |
Chemours Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Chemours insiders, such as employees or executives, is commonly permitted as long as it does not rely on Chemours' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Chemours insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Joseph Martinko over two weeks ago Disposition of 1302 shares by Joseph Martinko of Chemours at 14.95 subject to Rule 16b-3 | ||
Kava Joseph Daniel over two months ago Insider Trading | ||
Kristine Wellman over three months ago Acquisition by Kristine Wellman of 20671 shares of Chemours at 27.5 subject to Rule 16b-3 | ||
Picho Diane I. over three months ago Disposition of tradable shares by Picho Diane I. of Chemours at 19.04 subject to Rule 16b-3 | ||
Alvenia Scarborough over three months ago Acquisition by Alvenia Scarborough of 7903 shares of Chemours at 27.5 subject to Rule 16b-3 | ||
Shane Hostetter over six months ago Acquisition by Shane Hostetter of 26709 shares of Chemours subject to Rule 16b-3 | ||
Hostetter Shane over six months ago Insider Trading | ||
Camela Wisel over a year ago Acquisition by Camela Wisel of 5425 shares of Chemours subject to Rule 16b-3 |
Chemours Outstanding Bonds
Chemours issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Chemours uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Chemours bonds can be classified according to their maturity, which is the date when Chemours Co has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| US163851AH15 Corp BondUS163851AH15 | View | |
| US163851AF58 Corp BondUS163851AF58 | View | |
| Chemours 5375 percent Corp BondUS163851AE83 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Chemours Corporate Filings
8K | 10th of March 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 5th of March 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F3 | 4th of March 2025 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
| 7th of February 2025 Other Reports | ViewVerify |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chemours Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Is Diversified Chemicals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chemours. If investors know Chemours will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chemours listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.65) | Dividend Share 1 | Earnings Share 0.57 | Revenue Per Share | Quarterly Revenue Growth (0.01) |
The market value of Chemours is measured differently than its book value, which is the value of Chemours that is recorded on the company's balance sheet. Investors also form their own opinion of Chemours' value that differs from its market value or its book value, called intrinsic value, which is Chemours' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemours' market value can be influenced by many factors that don't directly affect Chemours' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chemours' value and its price as these two are different measures arrived at by different means. Investors typically determine if Chemours is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemours' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.